The evidence for the overall market has continued to worsen this week—all the major indexes have sliced below their 50-day lines, which has turned the intermediate-term trend down for the first time since April.
Read More
From Cabot Top Ten Trader
Right now, it’s hard to make (and keep) much money, so we continue to advise a cautious stance, with a good-sized cash position and being discerning on the buy side.
That said, we are actually seeing some legitimate positives in days...
Read More
October in an election year is historically a bad time for stocks. With that in mind, here are three sector ETFs to avoid completely.
Read More
Bad News, Good News
Our last issue was titled “Burden of Proof is on the Bulls,” and since then, the buyers have failed to step up to the plate, leading to a worsening of the overall evidence—earlier this week, our Cabot Tides flipped to bearish...
Read More
With 32 stocks in our portfolio and a market that’s going through all manner of gyrations right now, it’s time to part ways with a few of our underperforming positions.
Read More
It’s been another week of mixed stock performance and assorted headlines that collectively give me the sense that, while a lot of investors may be shifting money around, there’s no real consensus yet on what will work and what won’t in the near-term.
Read More
That tech stocks would cool a bit has been one of my key themes over the past few issues; and September has seen it come to pass.
Read More
Human genome sequencing has made huge strides in the last decade. And my two favorite sequencing stocks are 10x Genomics and NeoGenomics.
Read More
The market’s continued weakness has tipped our Cabot Tides to the negative side of the fence for the first time since April.
Read More
After pulling back over 8% from the high, the market is having trouble finding any traction. And the selling may not be over.
Read More
Back on August 13, when the broad market was strong and marijuana stocks were even stronger, I took partial profits in our four strongest stocks (which were also our four largest positions) because they looked very extended to the upside.
Read More
The Selloff Creates an Amazing Income Opportunity
The incredible rally from the March lows has been disrupted. After soaring a remarkable 60% from the March lows, the S&P has pulled back more than 8% from its early-September high. Where do we go from here?
Aside the...
Read More
If you know how to find small-cap stocks, you can consistently unlock better-than-average market returns. These five steps will help you find the right small caps.
Read More
Through most of the summer, investors had become increasingly confident about the strength and direction of the economic recovery, the likelihood of the arrival of several promising Covid vaccines, another round of federal economic stimulus and other favorable indicators.
Read More
As we move closer to October, the S&P 500 is down about 8% from its peak and this is no longer the longest start to a bull market.
Read More
This consumer electronics company is forecasted to grow at an annual rate of 15% over the next five years.
Read More
As market volatility returns, the most volatile stocks today have become untouchable. Here are three you should especially avoid.
Read More
This week we are going right back to a stock that we were involved with last month, which has handled the market weakness very well.
Read More
When we got into this stock we fully expected a lot of twists and turns. We didn’t expect the current drama.
Read More
Not many people do it, but it's important to set price targets on all your stocks the second you buy them. Here's how to do it.
Read More
